Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
about
Fc gamma receptor CD64 modulates the inhibitory activity of infliximabAnti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with PsoriasisAbnormal Distribution and Function of Monocyte Subsets in Patients With Primary Immune Thrombocytopenia.The transcriptome of human monocyte subsets begins to emerge.Monocytes: protagonists of infarct inflammation and repair after myocardial infarctionTreating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.Platelets induce a proinflammatory phenotype in monocytes via the CD147 pathway in rheumatoid arthritisThe utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.Chronic Psoriatic Skin Inflammation Leads to Increased Monocyte Adhesion and AggregationTherapeutic landscape for ulcerative colitis: where is the Adacolumn(®) system and where should it be?CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus.Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis.The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review.Current status and future perspectives of leukocytapheresis for inflammatory bowel disease.Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders.Clinical significance of monocyte heterogeneity.Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.Mucosal healing of esophageal involvement of Crohn's disease with granulocyte/monocyte adsorption.HLA-DR(hi) and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBD.Relevance of the processed blood volume per granulocyte and monocyte apheresis session to its clinical efficacy in patients with ulcerative colitis.The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.Resistance exercise training-induced decrease in circulating inflammatory CD14+CD16+ monocyte percentage without weight loss in older adults.Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: Efficacy of a non-drug intervention for patients refractory to pharmacologics.Immunoregulatory effects of adsorptive granulocyte and monocyte apheresis in patients with drug refractory Crohn's disease.Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupAdsorptive depletion of CD14⁺CD16⁺ proinflammatory monocyte phenotype in patients with generalized pustular psoriasis: clinical efficacy and effects on cytokines.>0 g, ≤5 g A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.
P2860
Q28482601-44C0EAC5-FBE8-47BC-B753-4F6319B8E0EEQ28554923-5E429530-0781-44F6-90C7-639807F03408Q33433318-5383999E-4399-4396-B0B0-CD54485F68FBQ33523382-C0CDE5D9-0D9F-4931-ADEC-2F0F4AB93385Q33942337-D09FEB34-30B6-4E33-BD69-30A186465F80Q34008773-28DD9CDA-4F5B-4FA1-854F-F5620A3D4EC8Q34958550-589038B1-8A62-4597-B34A-41FF016DD2E4Q34981525-13008737-5891-4A39-ADD2-ED278E91E955Q36305141-6EE1A08A-5F50-4167-BDE0-4E7876535999Q36390768-3F2010F5-24A2-4622-AF52-A2EC0E5B4853Q36522931-CF01672E-5EC9-45B5-A314-7C99FB1FAA49Q37425277-45098781-E8B9-43B0-8F47-4D2DA2A332B8Q37446568-06752D98-A493-452C-8E16-E5B09B8D97A5Q37809574-CAF65621-CC94-48D9-847B-DB766C1748BDQ37993226-3FB59DCB-15AE-475D-9E84-DDB2265ADEEBQ38243723-02B4A3F3-FE5B-4939-9AFF-C50DC3549B07Q38411099-FCD596ED-9256-4B85-8A43-96CAE1639342Q38810655-D8A5EE88-3F9C-4B0B-8AB7-265B3E300230Q39255696-C408BCCA-E017-402A-AB1D-DF8ACAAFFBC2Q40317388-28ABCDF2-13F4-436D-91A6-8C644A55245CQ42122500-6DD6DB84-E94F-4A99-BBC8-58E659164F53Q44433975-0C50DD91-1AD6-407D-B14D-C138B0623F12Q45579304-CA6853B3-9CA8-44F9-8BDB-A5654E44310EQ46303987-6E64F363-763B-4166-8FBA-741FE78B04FEQ47173280-AE14245A-B9E4-4781-A0B6-0168D1BD9624Q48296840-6D1CAE9B-1636-4FB0-BD5E-8F8D48A3E5C8Q53222255-68A2321F-40CC-4730-B059-A0970A4DCB67Q53343146-89A99EFA-235D-4120-8390-20ECACB5DF8BQ54445426-59B5089E-989C-4768-9EDF-06A4CF873DB8Q55444888-30F80080-B736-4D10-B5D7-3F7993976456
P2860
Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Adsorptive depletion of elevat ...... th inflammatory bowel disease.
@en
Adsorptive depletion of elevat ...... th inflammatory bowel disease.
@nl
type
label
Adsorptive depletion of elevat ...... th inflammatory bowel disease.
@en
Adsorptive depletion of elevat ...... th inflammatory bowel disease.
@nl
prefLabel
Adsorptive depletion of elevat ...... th inflammatory bowel disease.
@en
Adsorptive depletion of elevat ...... th inflammatory bowel disease.
@nl
P2093
P2860
P1476
Adsorptive depletion of elevat ...... th inflammatory bowel disease.
@en
P2093
Fumitoshi Watanabe
Hiroyuki Hanai
Kazuhisa Hirayama
Ken Takeuchi
Kenji Takai
Masami Yamada
Masataka Kikuyama
Seiji Nagata
Takayuki Iida
Yasushi Iwaoka
P2860
P304
P356
10.1111/J.1572-0241.2007.01714.X
P407
P577
2008-01-02T00:00:00Z